Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
UPDATE: Corbus Pharmaceuticals (CRBP) PT Raised to $28 at Cantor Fitzgerald
-
Corbus Pharmaceuticals Holdings, Inc. Announces Exercise of Option to Purchase Additional Shares in Public Offering
-
Corbus Pharma (CRBP) Prices 4.65M Common Stock Offering at $7/Share
-
Corbus Pharmaceuticals Holdings, Inc. Prices Underwritten Public Offering of Common Stock
-
Corbus Pharma (CRBP) Announces Proposed Public Common Offering
-
Corbus Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Corbus Pharma (CRBP): Notes From KOL Call - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight and $24 PT on Corbus Pharmaceuticals (CRBP); 'Pivotal Systemic Sclerosis (SSc) Study Unveiled'
-
Corbus Pharmaceuticals (CRBP) PT Raised to $24 at Cantor Fitzgerald Following Positive Study Data
-
Corbus Pharma (CRBP): Thoughts From R&D Day - Cantor
-
Corbus Pharma (CRBP): Notes From KOL Call - Cantor
-
Corbus Pharma (CRBP): KOL Call Supports Buy Thesis - Cantor Fitzgerald
-
After-Hours Stock Movers 11/23: (CTRP) (IIIN) Higher; (AIRG) (CRBP) Lower (more...)
-
Corbus Pharma (CRBP) Lower after Entering Agreement with Cantor on $35M Common Stock Offering
-
Cantor Fitzgerald Reiterates Bullish View on Corbus Pharmaceuticals (CRBP) on Resunab Success
-
Cantor Fitzgerald Defends Corbus Pharmaceuticals (CRBP) Following Short Report
-
Notable 52-Week Highs and Lows 10/5: (ECA) (REN) (CRBP) High; (TEVA) (TTD) Low
-
Unusual 11 Mid-Day Movers 10/5: (CPRX) (CRBP) (UEPS) Higher; (IMMU) (AZZ) (CTSO) Lower
-
Pre-Open Stock Movers 10/05: (CPRX) (ACIA) (TWTR) Higher; (IMMU) (ULH) (CRM) Lower (more...)
-
After-Hours Stock Movers 10/04: (ACIA) (CRBP) (TMH) Higher; (ULH) (CASC) (MU) Lower (more...)
-
Cantor Fitzgerald Starts Corbus Pharmaceuticals (CRBP) at Buy
-
Corbus Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 12, 2016

